HC Wainwright Reaffirms Buy Rating for Personalis (NASDAQ:PSNL)

HC Wainwright reiterated their buy rating on shares of Personalis (NASDAQ:PSNL) in a research report sent to investors on Wednesday,Benzinga reports. HC Wainwright currently has a $11.00 price objective on the stock.

Separately, Needham & Company LLC reissued a “buy” rating and issued a $7.25 target price on shares of Personalis in a report on Friday, December 20th.

Personalis Stock Down 0.2 %

Personalis stock opened at $5.59 on Wednesday. Personalis has a 12 month low of $1.12 and a 12 month high of $7.20. The stock has a market cap of $394.92 million, a price-to-earnings ratio of -3.33 and a beta of 1.75. The business has a 50 day moving average price of $4.70 and a two-hundred day moving average price of $4.33.

Personalis (NASDAQ:PSNL) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.31). The business had revenue of $25.71 million during the quarter, compared to the consensus estimate of $20.67 million. Personalis had a negative net margin of 104.52% and a negative return on equity of 66.07%. During the same period last year, the firm earned ($0.51) EPS. On average, analysts expect that Personalis will post -1.41 earnings per share for the current fiscal year.

Institutional Trading of Personalis

Several hedge funds have recently modified their holdings of the company. Barclays PLC increased its holdings in Personalis by 45.4% during the 3rd quarter. Barclays PLC now owns 65,468 shares of the company’s stock valued at $352,000 after purchasing an additional 20,444 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Personalis by 20.0% in the third quarter. Geode Capital Management LLC now owns 498,470 shares of the company’s stock valued at $2,683,000 after buying an additional 83,068 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of Personalis by 154.3% in the third quarter. Jane Street Group LLC now owns 164,281 shares of the company’s stock valued at $884,000 after buying an additional 99,671 shares during the last quarter. State Street Corp lifted its position in Personalis by 34.5% during the 3rd quarter. State Street Corp now owns 175,142 shares of the company’s stock worth $942,000 after buying an additional 44,900 shares in the last quarter. Finally, Centiva Capital LP bought a new stake in Personalis during the 3rd quarter worth about $380,000. Institutional investors and hedge funds own 61.91% of the company’s stock.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.